In Depth

eConsent in clinical trials: What’s on the horizon?

Breathing easy: How digital inhalers are changing asthma treatment

Primate models in pharma: What the future holds

A decade on, what’s next for CAR-T therapies?

FDA’s $7bn plan for 2024: Disclose CMOs, restart Cancer Moonshot